BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate Update
Go back to BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate Update| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.53 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.53 | 52 Week High | $1.63 | |||
| Open | $2.63 | 52 Week Low | $0.71 | |||
| Day High | $2.63 | P/E | N/A | |||
| Day Low | $2.43 | EPS | $0.00 | |||
| Volume | 11,866 | |||||
| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.53 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.53 | 52 Week High | $1.63 | |||
| Open | $2.63 | 52 Week Low | $0.71 | |||
| Day High | $2.63 | P/E | N/A | |||
| Day Low | $2.43 | EPS | $0.00 | |||
| Volume | 11,866 | |||||

